SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Jaaskelainen J,Luis DN,Paulus W. Haemangiopericytoma. In: KleihuesP,CaveneeWK, eds. Pathology and Genetics of Tumours of the Central Nervous System. Lyon, France: International Agency of Research on Cancer Press; 2000: 190192.
  • 2
    Hanahan D,Weinberg RA. The hallmarks of cancer. Cell. 2000; 100: 5770.
  • 3
    Serrano M,Lee H,Chin L,Cordon-Cardo C,Beach D,DePinho RA. Role of the INK4a locus in tumor suppression and cell mortality. Cell. 1996; 85: 2737.
  • 4
    Martinez JC,Palomino JC,Cabello A,Sepulveda JM,de la Camara AG,Ricoy JR. HDM2 over expression and focal loss of p14/ARF expression may deregulate the p53 tumour suppressor pathway in meningeal haemangiopericytomas. Study by double immunofluorescence and laser scanning confocal microscopy. Histopathology. 2005; 46: 184194.
  • 5
    Martin K,Trouche D,Hagemeier C,Sorensen TS,La Thangue NB,Kouzarides T. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature. 1995; 375: 691694.
  • 6
    Xiao ZX,Chen J,Levine AJ, et al. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature. 1995; 375: 694698.
  • 7
    Zhang Y,Xiong Y,Yarbrough WG. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumour suppression pathways. Cell. 1998; 92: 725734.
  • 8
    Brelje TC,Wessendorf MW,Sorenson RL. Multicolor laser scanning confocal immunofluorescence microscopy: practical application and limitations. Methods Cell Biol. 2002; 70: 165244.
  • 9
    Sanchez-Beato M,Camacho FI,Martinez-Montero JC, et al. Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 over expression. p27/KIP1-cyclin D3 co localization in tumour cells. Blood. 1999; 94: 765772.
  • 10
    Alen JF,Lobato RD,Gomez PA, et al. Intracranial hemangiopericytoma: study of 12 cases. Acta Neurochir (Wien). 2001; 143: 575586.
  • 11
    Alcazar JA,Polo JR,Tardio JC, et al. Comparative study of the expression of proteins involved in the cell cycle in renal secondary hyperparathyroidism. Kidney Int. 2003; 85( suppl): S28S31.
  • 12
    Sanchez E,Chacon I,Plaza MM, et al. Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins. J Clin Oncol. 1998; 16: 19311939.
  • 13
    Villuendas R,Sanchez-Beato M,Martinez JC, et al. Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression. Am J Pathol. 1998; 153: 887897.
  • 14
    Gazzeri S,Gouyer V,Vour'ch C, et al. Mechanisms of p16INK4A inactivation in non small-cell lung cancers. Oncogene. 1998; 16: 497504.
  • 15
    Martinez JC,Piris MA,Sanchez-Beato M, et al. Retinoblastoma (Rb) gene product expression in lymphomas. Correlation with Ki67 growth fraction. J Pathol. 1993; 169: 405412.
  • 16
    Martinez JC,Mateo MS,Sanchez-Beato M, et al. MDM2 expression in lymphoid cells and reactive and neoplastic lymphoid tissue. Comparative study with p53 expression. J Pathol. 1995; 177: 2734.
  • 17
    Ohbu M,Kobayashi N,Okayasu I. Expression of cell cycle regulatory proteins in the multistep process of oesophageal carcinogenesis: stepwise over-expression of cyclin E and p53, reduction of p21(WAF1/CIP1) and dysregulation of cyclin D1 and p27(KIP1). Histopathology. 2001; 39: 589596.
  • 18
    Sabah M,Cummins R,Leader M,Kay E. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications. Hum Pathol. 2006; 37: 648655.
  • 19
    Quintanilla-Martinez L,Davies-Hill T,Fend F, et al. Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis. Blood. 2003; 101: 31813187.
  • 20
    Cairns P,Polascik TJ,Eby Y, et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet. 1995; 11: 210212.
  • 21
    Ren B,Cam H,Takahashi Y, et al. E2F integrates cell cycle progression with DNA repair, replication, and G/M checkpoints. Genes Dev. 2002; 16: 245256.